1. Olson LJ, Somers VK. Modulation of Cardiovascular Risk Factors by Obstructive Sleep Apnea. Chest 2006; 129: 218–2.0
2. Meyer JS, Ishikawa Y, Hata T et al. Cerebral blood flow in normal and abnormal sleep and dreaming. Brain Cogn 1987; 6: 266–94.
3. ICSD-Internatinal Classification of Sleep Disorders: Diagnostic and Coding Manual. American Sleep Disorders Association. Allen Press, 1990.
4. Brooks D, Kozar L, Render-Telzelra C et al. Obstructive sleep apnea as a cause of systemic hypertension. J Clin Investigat 1997; 99 (1): 106–9.
5. Narkiewicz K, Somers VK. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens 1997; 15 (12): 1613–9.
6. Silverberg DS, Oksenberg A. Essential hypertension and abnormal upper airway resistance during sleep. Sleep 1997; 20 (9): 794–806
7. Narkiewicz K, van de Borne PJ, Montano N et al. Contribution of tonic chemoreflex activation to sympathetic activation and blood pressure in patients with obstructive sleep apnea. Circulation 1998; 97: 943–5.
8. Carlson JT, Rangemark C. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnea. J Hypertens 1996; 14 (5): 577–8.4
9. Hedner J. Vascular function in OSA. Sleep 1996; 19 (10): 213–7.
10. Saarelainen S, Seppala E. Circulating endothelin-1 in obstructive sleep apnea. Endothelium 1997; 5 (2): 115–8.
11. Remsburg S, Launois SH. Patients with obstructive sleep apnea have an abnormal peripheral vascular response to hypoxia. J Appl Physiol 1999; 87 (3): 1148.
12. Schnall RP, Shlitner A. Periodic, profound peripheral vasoconstriction–a new marker of obstructive sleep apnea. Sleep1999; 22 (7): 939–46.
13. Hall MJ, Bradley TD. Cardiovascular disease and sleep apnea. Curr Opin Pulm Med 1995; 1 (6): 512–8.